Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel T W Clarke

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Drug Delivery|September 19, 2014
Targeted drug delivery to the virus-infected airway; complications and remediesDaniel T W Clarke, Nigel A J McMillan
Oral Oncology|April 26, 2017
Can gene editing and silencing technologies play a role in the treatment of head and neck cancer?Mushfiq H Shaikh, Daniel T W Clarke, Newell W Johnson, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 24, 2004
A novel method for screening viral interferon-resistance genesDaniel T W Clarke, Aaron T Irving, Eleanore H Lambley, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 18, 2023
Prophylactic intranasal administration of lipid nanoparticle formulated siRNAs reduce SARS-CoV-2 and RSV lung infectionAroon Supramaniam, Yaman Tayyar, Daniel T W Clarke, et al.
Oral Oncology|November 10, 2018
Aurora kinases are a novel therapeutic target for HPV-positive head and neck cancersMushfiq H Shaikh, Adi Idris, Newell W Johnson, et al.
BMC Cancer|November 28, 2017
Prevalence and types of high-risk human papillomaviruses in head and neck cancers from BangladeshMushfiq H Shaikh, Aminul I Khan, Anwar Sadat, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Drug Delivery|September 19, 2014
Targeted drug delivery to the virus-infected airway; complications and remediesDaniel T W Clarke, Nigel A J McMillan
Oral Oncology|April 26, 2017
Can gene editing and silencing technologies play a role in the treatment of head and neck cancer?Mushfiq H Shaikh, Daniel T W Clarke, Newell W Johnson, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 24, 2004
A novel method for screening viral interferon-resistance genesDaniel T W Clarke, Aaron T Irving, Eleanore H Lambley, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 18, 2023
Prophylactic intranasal administration of lipid nanoparticle formulated siRNAs reduce SARS-CoV-2 and RSV lung infectionAroon Supramaniam, Yaman Tayyar, Daniel T W Clarke, et al.
Oral Oncology|November 10, 2018
Aurora kinases are a novel therapeutic target for HPV-positive head and neck cancersMushfiq H Shaikh, Adi Idris, Newell W Johnson, et al.
BMC Cancer|November 28, 2017
Prevalence and types of high-risk human papillomaviruses in head and neck cancers from BangladeshMushfiq H Shaikh, Aminul I Khan, Anwar Sadat, et al.
Pageof 1